P2X3 receptor antagonist in chronic cough--Authors' reply
- PMID: 26194520
- DOI: 10.1016/S0140-6736(15)61275-2
P2X3 receptor antagonist in chronic cough--Authors' reply
Comment on
-
P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.Lancet. 2015 Mar 28;385(9974):1198-205. doi: 10.1016/S0140-6736(14)61255-1. Epub 2014 Nov 25. Lancet. 2015. PMID: 25467586 Clinical Trial.
-
P2X3 receptor antagonist in chronic cough.Lancet. 2015 Jul 18;386(9990):244. doi: 10.1016/S0140-6736(15)61274-0. Lancet. 2015. PMID: 26194521 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
